MyFinsight
Home
Blog
About
Contact
ganx: the balance sheet
Download
Download image
Long-term deposits and
other noncurrent...
$33,694
Restricted cash
$36,117
Operating lease
right-of-use assets
$184,422
Internal-use software, net
$114,607
Property and equipment,
net
$85,572
Prepaid expenses and
other current assets
$1,438,400
Tax credits
$271,515
Cash and cash
equivalents
$8,807,353
Total noncurrent
assets
$454,412
Total current assets
$10,517,268
Total assets
$10,971,680
Total liabilities and
stockholders' equity
$10,971,680
Total stockholders'
equity
$5,909,430
Total liabilities
$5,062,250
Loss of the period
-$15,623,518
Accumulated deficit
-$81,194,908
Accumulated other
comprehensive income (loss)
$563,221
Additional paid-in capital
$102,161,036
Total noncurrent
liabilities
$891,648
Total current
liabilities
$4,170,602
Common stock, 0.0001
par value...
$3,599
Loans - noncurrent
$298,797
Operating lease liability
- noncurrent
$65,026
Defined benefit pension
plan
$527,825
Loans - current
$125,545
Deferred grant income -
current
$11,293
Other current
liabilities
$2,340,703
Operating lease liability
- current
$115,910
Accounts payable
$1,577,151
Back
Back
Balance Sheet
source: myfinsight.com
Gain Therapeutics, Inc. (GANX)
Gain Therapeutics, Inc. (GANX)